Paragon 28, Inc. Common Stock (FNA)
12.99
-0.04 (-0.31%)
Paragon 28 Inc is a medical device company focused on advancing innovation in the field of foot and ankle surgery
The company specializes in the development and commercialization of an extensive range of surgical implants and instruments designed to enhance patient outcomes and support orthopedic surgeons in their practice. Through its dedication to research and development, Paragon 28 aims to provide high-quality solutions that address various pathological conditions in the foot and ankle, enhancing both the effectiveness of surgical procedures and patient recovery.

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · March 3, 2025

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Paragon 28, Inc. (NYSEFNA) to Zimmer Biomet Holdings, Inc. for $13.00 per share in cash is fair to Paragon 28 shareholders. Paragon 28 shareholders will also receive a non-tradeable contingent value right entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved.
By Halper Sadeh LLC · Via Business Wire · March 3, 2025

NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · February 19, 2025

BALA CYNWYD, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · February 19, 2025

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · February 14, 2025

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · February 13, 2025

BALA CYNWYD, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · February 13, 2025

PHILADELPHIA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Paragon 28, Inc. (NYSEFNA):
By Grabar Law Office · Via GlobeNewswire · February 10, 2025

PHILADELPHIA, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globe Life Inc. (NYSEGL) FKA Torchmark NYSE: TMKNYSETMK)
By Grabar Law Office · Via GlobeNewswire · February 6, 2025

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · February 5, 2025

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · February 4, 2025

BALA CYNWYD, Pa., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · February 4, 2025

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Paragon 28, Inc. (NYSEFNA) to Zimmer Biomet Holdings, Inc. NYSE: ZBHNYSEZBH)
By Kahn Swick & Foti, LLC · Via Business Wire · January 29, 2025

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Paragon 28, Inc. (NYSEFNA) to Zimmer Biomet Holdings, Inc. for $13.00 per share in cash is fair to Paragon 28 shareholders. Paragon 28 shareholders will also receive a non-tradeable contingent value right entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved.
By Halper Sadeh LLC · Via Business Wire · January 29, 2025

Paragon 28, Inc. (NYSEFNA) (“Paragon 28” or “P28”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a range of its preliminary unaudited net revenue for the fourth quarter and full year ended December 31, 2024.
By Paragon 28, Inc. · Via Business Wire · January 13, 2025

Paragon 28, Inc. (NYSEFNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Chadi Chahine, CFO & EVP of Supply Chain Operations, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 7:30 a.m. Pacific Time / 8:30 a.m. Mountain Time.
By Paragon 28, Inc. · Via Business Wire · January 3, 2025

Paragon 28, Inc. (NYSEFNA), (the “Company”) a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has further strengthened its strategic oversight and governance capabilities.
By Paragon 28, Inc. · Via Business Wire · December 11, 2024

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. (“Paragon 28” or “the Company”) (NYSEFNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · November 29, 2024

LOS ANGELES, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. (“Paragon 28” or “the Company”) (NYSEFNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · November 28, 2024

PHILADELPHIA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSEFNA) on behalf of purchasers of Paragon 28 securities between May 5, 2023 and September 20, 2024, inclusive (the “Class Period”).
By Berger Montague · Via GlobeNewswire · November 25, 2024

NEW YORK, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSEFNA) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise acquired Paragon 28 common stock between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · November 24, 2024

PHILADELPHIA, Nov. 23, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSEFNA) on behalf of purchasers of Paragon 28 securities between May 5, 2023 and September 20, 2024, inclusive (the “Class Period”).
By Berger Montague · Via GlobeNewswire · November 23, 2024

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Paragon 28 To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · November 22, 2024

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · November 19, 2024

NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSEFNA) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise acquired Paragon 28 common stock between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · November 18, 2024